109 related articles for article (PubMed ID: 18652534)
1. Absence of H186R polymorphism in exon 4 of the APOBEC3G gene among North Indian individuals.
Rathore A; Chatterjee A; Yamamoto N; Dhole TN
Genet Test; 2008 Sep; 12(3):453-6. PubMed ID: 18652534
[TBL] [Abstract][Full Text] [Related]
2. Coding region variant 186H/R in Exon 4 of APOBEC3G among individuals of Western India.
Singh H; Marathe S; Nain S; Nema V; Angadi M; Bapat S; Pawar J; Ghate M; Sahay S; Gangakhedkar RR
APMIS; 2016 May; 124(5):401-5. PubMed ID: 26853443
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in the host restriction factor APOBEC3G are associated with HIV-1-related disease progression and central nervous system impairment in children.
Singh KK; Wang Y; Gray KP; Farhad M; Brummel S; Fenton T; Trout R; Spector SA
J Acquir Immune Defic Syndr; 2013 Feb; 62(2):197-203. PubMed ID: 23138837
[TBL] [Abstract][Full Text] [Related]
4. APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load.
Reddy K; Winkler CA; Werner L; Mlisana K; Abdool Karim SS; Ndung'u T;
AIDS; 2010 Jan; 24(2):195-204. PubMed ID: 19996938
[TBL] [Abstract][Full Text] [Related]
5. APOBEC3-mediated editing in HIV type 1 from pediatric patients and its association with APOBEC3G/CUL5 polymorphisms and Vif variability.
De Maio FA; Rocco CA; Aulicino PC; Bologna R; Mangano A; Sen L
AIDS Res Hum Retroviruses; 2012 Jun; 28(6):619-27. PubMed ID: 22145963
[TBL] [Abstract][Full Text] [Related]
6. Association of CCR5-59029 A/G and CCL3L1 copy number polymorphism with HIV type 1 transmission/progression among HIV type 1-seropositive and repeatedly sexually exposed HIV type 1-seronegative North Indians.
Rathore A; Chatterjee A; Sivarama P; Yamamoto N; Singhal PK; Dhole TN
AIDS Res Hum Retroviruses; 2009 Nov; 25(11):1149-56. PubMed ID: 19886839
[TBL] [Abstract][Full Text] [Related]
7. APOBEC3G genetic variants and their influence on the progression to AIDS.
An P; Bleiber G; Duggal P; Nelson G; May M; Mangeat B; Alobwede I; Trono D; Vlahov D; Donfield S; Goedert JJ; Phair J; Buchbinder S; O'Brien SJ; Telenti A; Winkler CA
J Virol; 2004 Oct; 78(20):11070-6. PubMed ID: 15452227
[TBL] [Abstract][Full Text] [Related]
8. Effect of HIV-1 Vif variability on progression to pediatric AIDS and its association with APOBEC3G and CUL5 polymorphisms.
De Maio FA; Rocco CA; Aulicino PC; Bologna R; Mangano A; Sen L
Infect Genet Evol; 2011 Aug; 11(6):1256-62. PubMed ID: 21571098
[TBL] [Abstract][Full Text] [Related]
9. Risk for HIV-1 infection is not associated with repeat-region polymorphism in the DC-SIGN neck domain and novel genetic DC-SIGN variants among North Indians.
Rathore A; Chatterjee A; Sood V; Khan SZ; Banerjea AC; Yamamoto N; Dhole TN
Clin Chim Acta; 2008 May; 391(1-2):1-5. PubMed ID: 18255039
[TBL] [Abstract][Full Text] [Related]
10. Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan population.
Ezzikouri S; Kitab B; Rebbani K; Marchio A; Wain-Hobson S; Dejean A; Vartanian JP; Pineau P; Benjelloun S
J Viral Hepat; 2013 Oct; 20(10):678-86. PubMed ID: 24010642
[TBL] [Abstract][Full Text] [Related]
11. Loci polymorphisms of the APOBEC3G gene in HIV type 1-infected Brazilians.
Bizinoto MC; Leal E; Diaz RS; Janini LM
AIDS Res Hum Retroviruses; 2011 Feb; 27(2):137-41. PubMed ID: 20874421
[TBL] [Abstract][Full Text] [Related]
12. Association of IL-4 589 C/T promoter and IL-4RalphaI50V receptor polymorphism with susceptibility to HIV-1 infection in North Indians.
Chatterjee A; Rathore A; Dhole TN
J Med Virol; 2009 Jun; 81(6):959-65. PubMed ID: 19382262
[TBL] [Abstract][Full Text] [Related]
13. APOBEC family proteins: novel antiviral innate immunity.
Takaori-Kondo A
Int J Hematol; 2006 Apr; 83(3):213-6. PubMed ID: 16720550
[TBL] [Abstract][Full Text] [Related]
14. APOBEC3G Variants and Protection against HIV-1 Infection in Burkina Faso.
Compaore TR; Soubeiga ST; Ouattara AK; Obiri-Yeboah D; Tchelougou D; Maiga M; Assih M; Bisseye C; Bakouan D; Compaore IP; Dembele A; Martinson J; Simpore J
PLoS One; 2016; 11(1):e0146386. PubMed ID: 26741797
[TBL] [Abstract][Full Text] [Related]
15. [Advances in the study of molecular mechanism of APOBEC3G anti-HIV-1].
Fan B; Cen S; Jiang JD
Yao Xue Xue Bao; 2008 Jul; 43(7):678-82. PubMed ID: 18819469
[TBL] [Abstract][Full Text] [Related]
16. Occurrence of APOBEC3G variations in West Indian HIV patients.
Singh H; Gangakhedkar RR
Microb Pathog; 2018 Aug; 121():325-330. PubMed ID: 29864532
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: a possible role in the resistance to HIV of HIV-exposed seronegative individuals.
Biasin M; Piacentini L; Lo Caputo S; Kanari Y; Magri G; Trabattoni D; Naddeo V; Lopalco L; Clivio A; Cesana E; Fasano F; Bergamaschi C; Mazzotta F; Miyazawa M; Clerici M
J Infect Dis; 2007 Apr; 195(7):960-4. PubMed ID: 17330785
[TBL] [Abstract][Full Text] [Related]
18. The level of APOBEC3G (hA3G)-related G-to-A mutations does not correlate with viral load in HIV type 1-infected individuals.
Ulenga NK; Sarr AD; Hamel D; Sankale JL; Mboup S; Kanki PJ
AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1285-90. PubMed ID: 18851679
[TBL] [Abstract][Full Text] [Related]
19. Association of RANTES -403 G/A, -28 C/G and In1.1 T/C polymorphism with HIV-1 transmission and progression among North Indians.
Rathore A; Chatterjee A; Sivarama P; Yamamoto N; Singhal PK; Dhole TN
J Med Virol; 2008 Jul; 80(7):1133-41. PubMed ID: 18461620
[TBL] [Abstract][Full Text] [Related]
20. Expression analysis of LEDGF/p75, APOBEC3G, TRIM5alpha, and tetherin in a Senegalese cohort of HIV-1-exposed seronegative individuals.
Mous K; Jennes W; Camara M; Seydi M; Daneau G; Mboup S; Kestens L; Van Ostade X
PLoS One; 2012; 7(3):e33934. PubMed ID: 22479480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
